These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30082517)

  • 1. Bronchiectasis Management in China, What We Can Learn from European Respiratory Society Guidelines.
    Wang N; Qu JM; Xu JF
    Chin Med J (Engl); 2018 Aug; 131(16):1891-1893. PubMed ID: 30082517
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibiotic-resistant
    Gao YH; Guan WJ; Zhu YN; Chen RC; Zhang GJ
    Int J Chron Obstruct Pulmon Dis; 2018; 13():237-246. PubMed ID: 29386892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of non-cystic fibrosis bronchiectasis].
    Martínez García MÁ; Máiz Carro L; Catalán Serra P
    Arch Bronconeumol; 2011 Dec; 47(12):599-609. PubMed ID: 21798654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of
    Vallières E; Tumelty K; Tunney MM; Hannah R; Hewitt O; Elborn JS; Downey DG
    Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28404646
    [No Abstract]   [Full Text] [Related]  

  • 5. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.
    Bilton D; Henig N; Morrissey B; Gotfried M
    Chest; 2006 Nov; 130(5):1503-10. PubMed ID: 17099030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on non-cystic fibrosis bronchiectasis.
    Bilton D
    Curr Opin Pulm Med; 2008 Nov; 14(6):595-9. PubMed ID: 18812838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotypic and phenotypic analyses of a Pseudomonas aeruginosa chronic bronchiectasis isolate reveal differences from cystic fibrosis and laboratory strains.
    Varga JJ; Barbier M; Mulet X; Bielecki P; Bartell JA; Owings JP; Martinez-Ramos I; Hittle LE; Davis MR; Damron FH; Liechti GW; Puchałka J; dos Santos VA; Ernst RK; Papin JA; Albertí S; Oliver A; Goldberg JB
    BMC Genomics; 2015 Oct; 16():883. PubMed ID: 26519161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe bronchiectasis in a patient with common variable immunodeficiency.
    Viegas LP; Silva SP; Silva SL; Campos Melo A; Serra-Caetano A; Branco-Ferreira M; Azevedo P; Pereira-Santos MC; Pereira-Barbosa M
    Eur Ann Allergy Clin Immunol; 2015 May; 47(3):95-8. PubMed ID: 25951148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality standards for the management of bronchiectasis in Italy: a national audit.
    Aliberti S; Hill AT; Mantero M; Battaglia S; Centanni S; Lo Cicero S; Lacedonia D; Saetta M; Chalmers JD; Blasi F;
    Eur Respir J; 2016 Jul; 48(1):244-8. PubMed ID: 27076581
    [No Abstract]   [Full Text] [Related]  

  • 10. Antimicrobial treatment of non-cystic fibrosis bronchiectasis.
    Grimwood K; Bell SC; Chang AB
    Expert Rev Anti Infect Ther; 2014 Oct; 12(10):1277-96. PubMed ID: 25156239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of immotile-dyskinetic cilia syndrome responding to clenbuterol hydrochloride and azithromycin].
    Itoh M; Kishi K; Nakamura H; Hatao H; Kioi K; Sudou A; Kobayasi K; Tuchida F; Adachi H; Yagyuu H; Oh-ishi S; Matsuoka T
    Nihon Kokyuki Gakkai Zasshi; 2002 Jul; 40(7):617-21. PubMed ID: 12382429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pseudomonas aeruginosa infections in chronic obstructive pulmonary disease : Role of long-term antibiotic treatment].
    Rohde GGU; Welte T
    Internist (Berl); 2017 Nov; 58(11):1142-1149. PubMed ID: 28983645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory medicine: bronchiectasis.
    ; Firth J
    Clin Med (Lond); 2019 Jan; 19(1):64-67. PubMed ID: 30651248
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chronic bronchial infection: the problem of Pseudomonas aeruginosa].
    Cantón R; Fernández Olmos A; de la Pedrosa EG; del Campo R; Antonia Meseguer M
    Arch Bronconeumol; 2011 Jun; 47 Suppl 6():8-13. PubMed ID: 21703473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eradication Therapy against Pseudomonas aeruginosa in Non-Cystic Fibrosis Bronchiectasis.
    Orriols R; Hernando R; Ferrer A; Terradas S; Montoro B
    Respiration; 2015; 90(4):299-305. PubMed ID: 26340658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrolide Treatment Inhibits Pseudomonas aeruginosa Quorum Sensing in Non-Cystic Fibrosis Bronchiectasis. An Analysis from the Bronchiectasis and Low-Dose Erythromycin Study Trial.
    Burr LD; Rogers GB; Chen AC; Hamilton BR; Pool GF; Taylor SL; Venter D; Bowler SD; Biga S; McGuckin MA
    Ann Am Thorac Soc; 2016 Oct; 13(10):1697-1703. PubMed ID: 27464029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
    Rogers GB; Bruce KD; Martin ML; Burr LD; Serisier DJ
    Lancet Respir Med; 2014 Dec; 2(12):988-96. PubMed ID: 25458200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections.
    Maciá MD; Blanquer D; Togores B; Sauleda J; Pérez JL; Oliver A
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3382-6. PubMed ID: 16048951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of long-term inhaled antibiotic for patients with noncystic fibrosis bronchiectasis: a meta-analysis.
    Yang JW; Fan LC; Lu HW; Miao XY; Mao B; Xu JF
    Clin Respir J; 2016 Nov; 10(6):731-739. PubMed ID: 25620629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pseudomonas aeruginosa colonisation in bronchiectatic patients and clinical reflections].
    Kömüs N; Tertemiz KC; Akkoçlu A; Gülay Z; Yilmaz E
    Tuberk Toraks; 2006; 54(4):355-62. PubMed ID: 17203422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.